human lactoferrin peptide 1-11
Phase 1/2Withdrawn 0 views this week 0 watching💤 Quiet
Interest: 14/100
14
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Staphylococcal Infections
Conditions
Staphylococcal Infections, Bacteremia
Trial Timeline
Feb 1, 2009 → Oct 1, 2009
NCT ID
NCT00509847About human lactoferrin peptide 1-11
human lactoferrin peptide 1-11 is a phase 1/2 stage product being developed by AM-Pharma for Staphylococcal Infections. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00509847. Target conditions include Staphylococcal Infections, Bacteremia.
What happened to similar drugs?
4 of 5 similar drugs in Staphylococcal Infections were approved
Approved (4) Terminated (2) Active (1)
Hype Score Breakdown
Clinical
9
Activity
0
Company
5
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00509847 | Phase 1/2 | Withdrawn |
| NCT00509938 | Phase 1/2 | Completed |
Competing Products
20 competing products in Staphylococcal Infections